Regkirona (regdanvimab) - Celltrion
REGEN-COV (casirivimab/imdevimab) - Regeneron, Roche
bebtelovimab (LY-CoV1404) - AbCellera, Eli Lilly
adintrevimab (ADG20) - Invivyd, Biocon
bamlanivimab (LY-CoV555) - Eli Lilly, AbCellera, National Institute of Allergy and Infectious Diseases
Xevudy (sotrovimab) - GSK, National Institutes of Health, Vir Biotech, National Institute of Allergy and Infectious Diseases
http://www.ncbi.nlm.nih.gov/pubmed/39126484
 
Daniele Focosi
 
Aug 11, 2024
 
Prev Next